PMVP
PMV Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.29
+4.03%Aug 31, 2026, 20:02 UTC
PMV Pharmaceuticals announced the commencement of an underwritten public offering of common stock and warrants, including pre-funded warrants, to raise capital.
Aug 14, 2026, 12:00 UTC
PMV Pharmaceuticals reported its financial results for the second quarter ended June 30, 2026.
Source: